By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Direct-to-consumer genomics firm 23andMe today announced it has raised an additional $9 million in its Series C financing round, bringing the total funding in the round to $31 million.

MPM Capital joined Johnson & Johnson Development Corp. as a new investor, the Mountain View, Calif.-based firm said. Ashley Ledbetter Dombkowski, a director at MPM, is joining 23andMe's board, it added.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.